United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%
Source ↗
👁 0
💬 0
The post United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42% appeared first on 24/7 Wall St..
After the market closed on October 13, 2026, Liquidia (NASDAQ:LQDA) settled every pending lawsuit with United Therapeutics (NASDAQ:UTHR) for net payments totaling $380.7 million. Its stock rose 42.60% to $38.23 as of 7:59 p.m. Eastern. That gain came even though the bill represents about 16% of its $2.40 billion market value and the deal removes an approved use from i
After the market closed on October 13, 2026, Liquidia (NASDAQ:LQDA) settled every pending lawsuit with United Therapeutics (NASDAQ:UTHR) for net payments totaling $380.7 million. Its stock rose 42.60% to $38.23 as of 7:59 p.m. Eastern. That gain came even though the bill represents about 16% of its $2.40 billion market value and the deal removes an approved use from i
Comments (0)